Bruker Operating Margin 2010-2024 | BRKR
Current and historical operating margin for Bruker (BRKR) over the last 10 years. The current operating profit margin for Bruker as of December 31, 2024 is 10.71%.
| Bruker Operating Margin Historical Data |
| Date |
TTM Revenue |
TTM Operating Income |
Operating Margin |
| 2024-12-31 |
$3.37B |
$0.25B |
7.51% |
| 2024-09-30 |
$3.24B |
$0.29B |
8.79% |
| 2024-06-30 |
$3.12B |
$0.34B |
10.93% |
| 2024-03-31 |
$3.00B |
$0.38B |
12.63% |
| 2023-12-31 |
$2.96B |
$0.44B |
14.74% |
| 2023-09-30 |
$2.82B |
$0.46B |
16.47% |
| 2023-06-30 |
$2.71B |
$0.47B |
17.35% |
| 2023-03-31 |
$2.62B |
$0.46B |
17.52% |
| 2022-12-31 |
$2.53B |
$0.43B |
17.11% |
| 2022-09-30 |
$2.51B |
$0.43B |
17.05% |
| 2022-06-30 |
$2.48B |
$0.41B |
16.53% |
| 2022-03-31 |
$2.46B |
$0.42B |
17.13% |
| 2021-12-31 |
$2.42B |
$0.41B |
17.08% |
| 2021-09-30 |
$2.36B |
$0.40B |
16.97% |
| 2021-06-30 |
$2.27B |
$0.37B |
16.29% |
| 2021-03-31 |
$2.12B |
$0.32B |
15.15% |
| 2020-12-31 |
$1.99B |
$0.25B |
12.47% |
| 2020-09-30 |
$1.96B |
$0.25B |
12.91% |
| 2020-06-30 |
$1.97B |
$0.26B |
13.20% |
| 2020-03-31 |
$2.04B |
$0.28B |
13.56% |
| 2019-12-31 |
$2.07B |
$0.30B |
14.58% |
| 2019-09-30 |
$2.03B |
$0.29B |
14.31% |
| 2019-06-30 |
$1.97B |
$0.27B |
13.74% |
| 2019-03-31 |
$1.93B |
$0.27B |
13.81% |
| 2018-12-31 |
$1.90B |
$0.26B |
13.81% |
| 2018-09-30 |
$1.87B |
$0.25B |
13.39% |
| 2018-06-30 |
$1.84B |
$0.23B |
12.64% |
| 2018-03-31 |
$1.81B |
$0.22B |
12.07% |
| 2017-12-31 |
$1.77B |
$0.22B |
12.39% |
| 2017-09-30 |
$1.71B |
$0.21B |
12.08% |
| 2017-06-30 |
$1.66B |
$0.20B |
12.08% |
| 2017-03-31 |
$1.62B |
$0.19B |
11.47% |
| 2016-12-31 |
$1.61B |
$0.18B |
11.30% |
| 2016-09-30 |
$1.62B |
$0.17B |
10.56% |
| 2016-06-30 |
$1.62B |
$0.15B |
9.44% |
| 2016-03-31 |
$1.65B |
$0.17B |
10.03% |
| 2015-12-31 |
$1.62B |
$0.15B |
8.99% |
| 2015-09-30 |
$1.65B |
$0.12B |
7.26% |
| 2015-06-30 |
$1.68B |
$0.10B |
5.78% |
| 2015-03-31 |
$1.74B |
$0.10B |
5.75% |
| 2014-12-31 |
$1.81B |
$0.11B |
5.86% |
| 2014-09-30 |
$1.85B |
$0.12B |
6.58% |
| 2014-06-30 |
$1.87B |
$0.15B |
7.96% |
| 2014-03-31 |
$1.87B |
$0.16B |
8.45% |
| 2013-12-31 |
$1.84B |
$0.15B |
8.10% |
| 2013-09-30 |
$1.80B |
$0.13B |
7.04% |
| 2013-06-30 |
$1.81B |
$0.16B |
8.55% |
| 2013-03-31 |
$1.78B |
$0.13B |
7.48% |
| 2012-12-31 |
$1.79B |
$0.16B |
8.65% |
| 2012-09-30 |
$1.75B |
$0.17B |
9.71% |
| 2012-06-30 |
$1.72B |
$0.15B |
8.60% |
| 2012-03-31 |
$1.70B |
$0.17B |
9.71% |
| 2011-12-31 |
$1.65B |
$0.16B |
9.51% |
| 2011-09-30 |
$1.59B |
$0.16B |
9.74% |
| 2011-06-30 |
$1.48B |
$0.16B |
10.51% |
| 2011-03-31 |
$1.38B |
$0.16B |
11.20% |
| 2010-12-31 |
$1.31B |
$0.16B |
11.95% |
| 2010-09-30 |
$1.26B |
$0.18B |
14.34% |
| 2010-06-30 |
$1.21B |
$0.17B |
13.80% |
| 2010-03-31 |
$1.16B |
$0.15B |
12.82% |
| 2009-12-31 |
$1.12B |
$0.14B |
12.20% |
| Sector |
Industry |
Market Cap |
Revenue |
| Computer and Technology |
Scientific Instruments Manufacturing |
$7.866B |
$3.366B |
|
Bruker Corp designs & manufactures proprietary life science & materials research systems & associated products that serve multiple customers in life science research, pharmaceuticals, applied markets, nanotechnology, cell biology, clinical research, microbiology & in-vitro diagnostics. BSI Life Science reports under two groups: Bruker BioSpin Group & Bruker CALID Group. The Bruker BioSpin comprises the Bruker Magnetic Resonance & Preclinical Imaging divisions, which designs, manufactures & distributes enabling life science tools based on the magnetic resonance technology. The Bruker CALID comprises the Bruker Daltonics & primarily designs, manufactures & distributes life-science mass spectrometry instruments that can be integrated with other sample preparation or chromatography instruments. BSI Nano designs, manufactures & distributes advanced X-ray instruments to determine the characteristics of matter & the three-dimensional structure of molecules.
|
